Lanxess Announces Major Workforce Reduction Amid Deepening Losses

German chemical firm Lanxess reports major loss, launches deeper cost cuts and job reductions to counter weak demand and Asian competition, with recovery not expected before late 2026.

The German specialty chemicals group Lanxess is intensifying its cost-cutting program following a deeply loss-making fiscal year. The company reported a net loss of 577 million euros and unveiled plans to eliminate 550 positions, highlighting the severe challenges facing the Cologne-based firm. While structural adjustments aim to shore up profitability, a sustainable operational turnaround is not anticipated before the second half of 2026.

Financial Performance Under Pressure

A difficult year was characterized by weak demand and significant price pressure across the industry. Group revenue fell by nearly eleven percent to 5.67 billion euros. The Advanced Intermediates segment was a particular drag on performance, where EBITDA collapsed by 39 percent due to low plant utilization. Only the Consumer Protection unit provided relative stability, serving as a reliable anchor in the portfolio with a steady operating margin of 15 percent.

In response to these negative trends, management has initiated additional permanent cost reductions amounting to 100 million euros annually. The job cuts will predominantly affect German sites, accounting for two-thirds of the total, with a primary focus on administrative functions. This strategic move is a direct counter to intensified competition from Asia, which continues to compress margins in Lanxess's core business areas.

Market Reaction and Liquidity Position

Investors delivered a stark verdict on the company's cautious outlook. On Friday, the stock declined further, hitting a new 52-week low of 11.78 euros. A drop of approximately 40 percent in just the last 30 days reflects eroding investor confidence. Despite the operational headwinds, company leadership emphasizes a solid liquidity position of 500 million euros and currently rules out a capital increase.

Strategic Divestment and Cautious Outlook

To generate additional financial flexibility, Lanxess plans a gradual divestment of its stake in the Envalior joint venture. The company is targeting proceeds in the high triple-digit million-euro range. These funds are intended to help stabilize the balance sheet, as the core business is expected to remain at the low level of the previous quarter through the first quarter of 2026.

For the full 2026 fiscal year, Lanxess forecasts adjusted EBITDA between 450 and 550 million euros. A noticeable recovery in demand is not expected before the third quarter, and even then, it is contingent on planned economic stimulus programs in the infrastructure sector taking effect. Until that point, stringent cost discipline will remain the crucial lever for navigating the persistent downturn in the chemical industry.